On The Pen GLP-1 News

Eli Lilly Just Revealed Something About The GLP-1 Market

30 Apr 2026

Contributed by Lukas

We just got done listening to the quarter one, 2026 Eli Lilly earnings call. There was a lot of information to get into, whether you're interested...

SURVODUTIDE Phase 3 Data: Why Weight Loss Isn't The Whole Story

28 Apr 2026

Contributed by Lukas

https://www.otplinks.comA new GLP-1 and glucagon agonist dropped data that was supposed to rival retatrutide, just without the GIP, and on the surface...

BPI STOPS TIRZEPATIDE Production, Second Major Pharmacy Out!

23 Apr 2026

Contributed by Lukas

Major disruption hits the GLP-1 landscape as another large 503B compounding pharmacy halts production of semaglutide and tirzepatide. In this episode,...

Retatrutide Could Change Everything… But Who Actually Gets It?

21 Apr 2026

Contributed by Lukas

ON THE PEN RESOURCES AND LINKS: HTTPS://WWW.OTPLINKS.COMWhat if the most powerful obesity drug ever created ends up being the one you can’t get?That...

Ozempic Personality With Dr Spencer Nadolsky

19 Apr 2026

Contributed by Lukas

This conversation dives headfirst into one of the most controversial and least understood side effects of GLP-1 medications, what many are now calling...

Foundayo GLP-1 Pill: FDA Needs More Data

14 Apr 2026

Contributed by Lukas

Orforglipron (also known as Foundayo) is one of the most promising drugs in the GLP-1 space, notably as only the second oral GLP-1 option for obesity....

GLP-1 Access State of the Union

07 Apr 2026

Contributed by Lukas

If you just look at the headlines, things look great for access to GLP-1 medications but for some of those already using these medications things are ...

Zepbound Dosing: What Your Doctor Didn't Explain

02 Apr 2026

Contributed by Lukas

Are you on tirzepatide or semaglutide and struggled with inconsistent weight loss and side effects? On this episode of On The Pen, Dave Knapp and Dr. ...

Wegovy Price Drop Exposes a Bigger Problem

31 Mar 2026

Contributed by Lukas

A major shift in obesity treatment is underway following a surprising pricing move that could change how patients access care. This episode explores t...

Retatrutide Is Too Good… And That’s The Problem

24 Mar 2026

Contributed by Lukas

Access to compounded and research-grade GLP-1s may be tightening, as comments from Robert F. Kennedy Jr. signal increased enforcement and a push back ...

MASSIVE: Compound Tirzepatide and Semaglutide Updates!

17 Mar 2026

Contributed by Lukas

On The Pen breaks down the latest GLP-1 news, compounded semaglutide updates, tirzepatide controversy, FDA and DDC list developments, Novo Nordisk fin...

BREAKING NEWS: Medicare to Cover Zepbound for $50, But CMS Just Issued a Catch

10 Mar 2026

Contributed by Lukas

Send a textOn this episode of the podcast, host Dave Knapp breaks down the latest updates on potential GLP-1 receptor agonists coverage for people on ...

The Gray Market Is Booming Because GLP-1 Access Is Broken

03 Mar 2026

Contributed by Lukas

Send a textEpisode Summary (Short Version):This week on On The Pen, Dave breaks down the rapid changes reshaping GLP-1 access — from new federal ref...

NEW GLP3 FROM NOVO NORDISK! BETTER THAN RETATRUTIDE?

24 Feb 2026

Contributed by Lukas

Send a textThis episode unpacks Novo’s aggressive price cuts, Lilly’s head to head trial win, and the emerging triple agonist race, revealing how ...

Wegovy vs Zepbound in 2026: New Higher Dose

17 Feb 2026

Contributed by Lukas

Send a textWegovy’s new 7.2 mg dose—three times higher than the current max—has just been approved in the EU, with U.S. approval expected soon. ...

Compound Tirzepatide: Time to Stock Up?

10 Feb 2026

Contributed by Lukas

Send a textThis week on The Weekly Dose, Dave Knapp breaks down the biggest questions shaking up the GLP-1 world. From whether patients should be stoc...

Eli Lilly Earnings Call Q4 2025 Recap

04 Feb 2026

Contributed by Lukas

Send us a textThis week on On The Pen: The Weekly Dose, Dave breaks down one of the most consequential Eli Lilly earnings calls to date. We dive into ...

Once Monthly GLP-1 Injection?!

03 Feb 2026

Contributed by Lukas

Send us a textThis week on On The Pen: The Weekly Dose, we break down Pfizer’s $10 billion bet on obesity medicine and whether it’s shaping up to ...

A PCOS and Tirzepatide Trial. Finally

27 Jan 2026

Contributed by Lukas

Send us a textCan Zepbound treat PCOS? That's the question this clinical trial will seek to answer, and we cover it exclusively on this week&apos...

Over The Counter GLP-1 Soon?

20 Jan 2026

Contributed by Lukas

Send us a textIn this episode of On The Pen: The Weekly Dose, Dave Knapp breaks down why the idea of over-the-counter GLP-1 medications isn’t radica...

GLP-1 PLUS Gastric Balloon for added Weight Loss!

19 Jan 2026

Contributed by Lukas

Send us a textShantanu Gaur, CEO of Allurion, returns to the podcast to break down their swallowable inflatable weight loss balloon, how it works, who...

GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care

13 Jan 2026

Contributed by Lukas

Send us a textThis week on On The Pen, we break down a rare FDA walk-back on GLP-1 safety labeling, major pharma signals coming out of JPM 2026, and t...

Wegovy Pens Recalled & Wegovy Pill Launch

06 Jan 2026

Contributed by Lukas

This episode opens the year with one of the most consequential—and complicated—weeks in GLP-1 obesity medicine. We break down three stories that, ...

Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!

23 Dec 2025

Contributed by Lukas

https://www.OTPLinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data f...

GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme

19 Dec 2025

Contributed by Lukas

Pharma Influence & Why Patient Voices Matter Lobbying Power: Eli Lilly, Novo Nordisk, and Government Access Why GLP-1 Medication Access Is at Risk...

Compounded Retatrutide? What the Judge Said

16 Dec 2025

Contributed by Lukas

Retatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what thi...

Retatrutide Weight Loss: How Much At Each Dose

13 Dec 2025

Contributed by Lukas

https://www.otplinks.com 0:00 Welcome & today’s focus: Retatrutide and “chasing the biggest number” 1:11 On The Pen intro, live schedule (Mo...

Mounjaro vs. New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight

09 Dec 2025

Contributed by Lukas

Episode Timeline & Main Topics 00:00 — Opening & Community Update • First week doing the podcast fully live thanks to the On The Pen commu...

GLP-1: New Metrics, New Molecules, New Prices

02 Dec 2025

Contributed by Lukas

Topics We Cover: 00:00 – New data from Harvard/Mass General may classify nearly 70% of adults as having obesity 03:00 – A new oral triple agonist ...

Novo Nordisk Amycretin Shocker + Semaglutide Flopper

25 Nov 2025

Contributed by Lukas

Follow Us Everywhere: https://www.otplinks.com Sign up for Emails: https://www.obesity.news Hosted by Simplecast, an AdsWizz company. See pcm.adswizz....

Wegovy GLP-1 Price Novo Blinks First

18 Nov 2025

Contributed by Lukas

Het Exclusive OTP Discounts! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal da...

GLP-1 State of the Union

11 Nov 2025

Contributed by Lukas

Get Exclusive OTP Savings! Https://www.otplinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection...

Lower Cost Zepbound and Wegovy? TrumpRX Announcement Incoming

04 Nov 2025

Contributed by Lukas

Exclusive OTP Savings HTTPS://www.otplinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and ...

Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide Announced!

30 Oct 2025

Contributed by Lukas

EXCLUSIVE SAVINGS FOR YOU! www.OTPLinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use...

Retatrutide + Tirzepatide Grey Market Clampdown + 1 Billion GLP-1 Pills Incoming

28 Oct 2025

Contributed by Lukas

GET EXCLUSIVE OTP SAVINGS! www.OTPLinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use...

HLTH 2025: Obesity Care Superstar Interviews

22 Oct 2025

Contributed by Lukas

VIEW EXCLUSIVE OTP SAVINGS! http://otplinks.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection an...

TRUMP: Ozempic Will Soon be $150 in the US! Meet the Reporter Who Made Him Say It!

17 Oct 2025

Contributed by Lukas

GET ACCESS TO OBESITY CARE AND MEDS AND SUPPORT OTP: https://lddy.no/1ndi6 USE CODE: OTP25 VISIT ALL OUR LINKS: https://linktr.ee/manonthemounjaro Hos...

Wegovy and Ozempic Users: FDA's Scathing Report on Major Novo Factory

14 Oct 2025

Contributed by Lukas

Visit our Sponsors and check out EXCLUSIVE OTP Savings! www.OTPLinks.com www.tryshed.com (use code OTP25 to save 25%) Hosted by Simplecast, an AdsWizz...

Retatrutide News That Could Change Everything for GLP-1 Compounds

07 Oct 2025

Contributed by Lukas

SUPPORT OUR WORK: OTPLinks.com 💉 Story 1 — Fractyl Health’s One-and-Done Gene Therapy for Obesity Fractyl Health just dropped preclinical resul...

Sobriety Meets Weight Loss: The Ethan Suplee Interview

07 Oct 2025

Contributed by Lukas

View All My Links: https://www.OTPLinks.com Join Ethan's Live: 2way.tv/ethansuplee Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for i...

Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine

03 Oct 2025

Contributed by Lukas

otplinks.com stallybrand.com (code OTP10) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use o...

Stopping Zepbound and Maintaining with Revita

30 Sep 2025

Contributed by Lukas

otplinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertisi...

GLP-1 Treatment and Advocacy with Dr. Leslie Golden

26 Sep 2025

Contributed by Lukas

https://linktr.ee/manonthemounjaro Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of perso...

Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update

23 Sep 2025

Contributed by Lukas

https://linktr.ee/manonthemounjaro Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of perso...

GLP-1 Weight Loss, Why It's About So Much More for Patients

19 Sep 2025

Contributed by Lukas

View All Our Links and Resources! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of person...

Compound GLP-1 Legislation + FDA Warning Letter to HIMS

16 Sep 2025

Contributed by Lukas

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure

09 Sep 2025

Contributed by Lukas

🔗 My Linktree with all resources: LINktr.ee/manonthemounjaro

Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!

02 Sep 2025

Contributed by Lukas

Visit All Our Links https://linktr.ee/manonthemounjaro GLP-1 Heart Study https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the

Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi

30 Aug 2025

Contributed by Lukas

Visit our links: https://linktr.ee/manonthemounjaro

Eli Lilly VS Mochi Update + Big Lilly Orforglipron Secret Revealed

26 Aug 2025

Contributed by Lukas

Links referenced in podcast: https://linktr.ee/manonthemounjaro

Eli Lilly Orforglipron Secret Revealed! + Lill VS Mochi Update

26 Aug 2025

Contributed by Lukas

Send us a textIn this week's episode we unpack some Orforglipron breaking news, plus a preview of this week's Eli Lilly VS Mochi lawsuit hea...

Ozempic Price Cut + New Obesity Pill Data

19 Aug 2025

Contributed by Lukas

https://linktr.ee/manonthemounjaro

GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program

13 Aug 2025

Contributed by Lukas

Visit All Our Links: https://linktr.ee/manonthemounjaro

Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

07 Aug 2025

Contributed by Lukas

VISIT ALL OUR LINKS: https://linktr.ee/manonthemounjaro 📩 Subscribe to On The Pen on Substack for breaking GLP-1 news and advocacy: https://onthepe...

Novo Nordisk Blames Compound Semaglutide on Slower Sales

07 Aug 2025

Contributed by Lukas

VISIT OUR LINKS: https://linktr.ee/manonthemounjaro

No Compounded Retatrutide Says the FDA + Tons of GLP-1 News

05 Aug 2025

Contributed by Lukas

Visit Our Links: https://linktr.ee/manonthemounjaro

LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and Wegovy for Obesity

01 Aug 2025

Contributed by Lukas

VISIT ALL OUR LINKS: https://linktr.ee/manonthemounjaro

Retatrutide Drops are Crazy // OTP TWD 7.29.25

29 Jul 2025

Contributed by Lukas

Visit Our Links: https://linktr.ee/manonthemounjaro

Compound GLP-1 Injections : You Won't Believe What The Obesity Society is Saying

22 Jul 2025

Contributed by Lukas

All Our Links: https://linktr.ee/manonthemounjaro Obesity Newsletter: https://www.obesity.news https://onthepen.substack.com/p/stunning-news-zepbound-...

Connecticut Making Ozempic!? Meet The Mastermind

18 Jul 2025

Contributed by Lukas

All Referenced Links: https://linktr.ee/manonthemounjaro

SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25

15 Jul 2025

Contributed by Lukas

This week, Dave covers massive GLP-1 news out of Connecticut, a new GLP-1 heart study that changes the conversation, and a big OTP event opportunity a...

BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?

08 Jul 2025

Contributed by Lukas

https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https...

Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview

05 Jul 2025

Contributed by Lukas

Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro

Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25

01 Jul 2025

Contributed by Lukas

https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https...

Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25

24 Jun 2025

Contributed by Lukas

Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro

Faces of The Fight: The Jamie Selzler Story

23 Jun 2025

Contributed by Lukas

At 650 pounds, GLP-1 injections helped give Jamie His Life Back. Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all...

Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25

17 Jun 2025

Contributed by Lukas

SUPPORT OUR WORK AND GET MORE NEWS! https://linktr.ee/manonthemounjaro

GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25

10 Jun 2025

Contributed by Lukas

https://www.linktr.ee/manonthemounjaro Ozempic rare eye disease update The the race for once monthly dosing Big insurance wins incoming?!

Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens

03 Jun 2025

Contributed by Lukas

VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM

Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

20 May 2025

Contributed by Lukas

Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro

Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything

13 May 2025

Contributed by Lukas

Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro

Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25

06 May 2025

Contributed by Lukas

Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and ...

CVS Drops Zepbound + Lilly Earnings Call Recap

01 May 2025

Contributed by Lukas

CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown. Join the Substack: htt...

Compound GLP-1 PubMed Data: What It Didn’t Tell Us

29 Apr 2025

Contributed by Lukas

Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t We...

High Dose Semaglutide Incoming! How Much Will it Cost? // OTP TWD 4.22.25

22 Apr 2025

Contributed by Lukas

WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code ...

Getting Insurance To Cover Skin Removal Surgery // OTP Eps 109

19 Apr 2025

Contributed by Lukas

The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️ ...

Counterfeit Ozempic at Pharmacies! // OTP TWD 4.15.25

15 Apr 2025

Contributed by Lukas

The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️ ...

GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108

11 Apr 2025

Contributed by Lukas

The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️ ...

Grow-Zempic!? These Students Discoverd a GLP-1 Plant!

11 Apr 2025

Contributed by Lukas

WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code ...

Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad

09 Apr 2025

Contributed by Lukas

WAYS TO SUPPORT MY WORK ⬇️ 💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: BPC-157 // Can’t Weight // TB4-FRAG // KPV Sign up here and use code ...

GLP-1 Medicare Coverage: What is Going On // OTP TWD 04.08.2025

08 Apr 2025

Contributed by Lukas

Ozempic, Trulicity and Victoza are decreasing dementia by 45%, so what is going on with Medicare coverage for obesity medicine? The Knapp family was f...

Are GLP-1 Meds For Life? Fractyl’s CEO Says “Not So Fast!”

06 Apr 2025

Contributed by Lukas

💊 Orally Bioavailable Peptides: Sign up here and use code “OTP10” to save 10% https://integrativepeptides.com/OTP Why I trust Integrative Pepti...

Fake Sugar: 👍 or 👎 for Weight Loss With Dr. Spencer Nadolsky // OTP Eps 107

04 Apr 2025

Contributed by Lukas

Dave sits down with a favorite OTP guest, Dr. Spencer Nadolsky of the Docs Who Lift Podcast to discuss a recent study that asked, “Does Sucralose In...

Tirzepatide Compounds: Lilly Sues Pharmacies // OTP TWD 04.01.25

01 Apr 2025

Contributed by Lukas

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: htt...

Zepbound Weight Loss Stalls: Tips and Tricks // OTP Eps 106

29 Mar 2025

Contributed by Lukas

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: htt...

Rare Exclusive Interview: OFA Chairman Sits Down with OTP to Talk Tirzepatide Lawsuit

26 Mar 2025

Contributed by Lukas

In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscap...

Novo’s Retatrutide Competitor

25 Mar 2025

Contributed by Lukas

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: htt...

Ozempic: Setting the Microdosing Strategy Straight w/ Dr Tyna Moore // OTP EPS 105

14 Mar 2025

Contributed by Lukas

​⁠’s course, use code “OTP20” to save 20%! https://www.drtyna.com/offers/VstUywXc/checkout Decoding GLP-1: A Guide for Friends and Family of...

Compound Tirzepatide Latest // Cagrisema Disappoints Again // Great Vikingtide News

11 Mar 2025

Contributed by Lukas

Dave discusses the latest in the compound tirzepatide legal battles, cagrisema delivers more big let downs, and some exciting news about VK2735 aka V...

Obesity Bias in Medicine With Dr. Toomer // OTP Eps 104

07 Mar 2025

Contributed by Lukas

Dr. Catherine Harmon Toomer is a board certified Family Medicine physician, certified hypnotherapist & NLP practitioner, founder of TOTAL Weight C...

Compound GLP-1 Accessibility + World Obesity Day // OTP TWD 03.04.25

04 Mar 2025

Contributed by Lukas

The latest in compounded semaglutide and tirzepatide, as well as the meaning behind World Obesity Day Decoding GLP-1: A Guide for Friends and Family o...

Compound Tirzepatide Latest Updates // @Mike.OnAMssion2 Joins // OTP Eps 103

28 Feb 2025

Contributed by Lukas

GLP-1 community builder Mike Donnelly-Boylen joins Dave to discuss his health mission and experience losing 100 pounds with Mounjaro! Decoding GLP-1: ...

Lilly Drops Zepbound Price, Compounders Sue FDA (again) OTP TWD 2.25.25

25 Feb 2025

Contributed by Lukas

Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potent...

Compound Tirzepatide Lawsuit Update / GLP-1 Heart Health w Dr Simin Lee / OTP Eps 102

21 Feb 2025

Contributed by Lukas

OTP legal expert Lee Thomas joins to discuss the latest in the compound Tirzepatide lawsuit. Dr Simin Lee joins Dave to discuss obesity, GLP-1 medicat...

503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25

18 Feb 2025

Contributed by Lukas

📚 Book Relaunch: The book “Decoding GLP-1” is back on Amazon, now priced at $10, thanks to community advocacy. ⏳ Compounding Update: The FDA ...

Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101

14 Feb 2025

Contributed by Lukas

On the 101st episode of On The Pen Live, Dave discusses this week's news in GLP-1, we get weight loss maintenance tips from Korrie, and a Reddit recap...

Lilly Announces Next Gen Tirzepatide

11 Feb 2025

Contributed by Lukas

Breaking Compound Tirzepatide News Lilly announces next generation of GLP-1 / GIP med Trump advocates for cheaper "Fat Shot" HIMS faces indu...

GLP-1 Talk Show: An Emotional 100th On The Pen Live

07 Feb 2025

Contributed by Lukas

In the 100th episode of On The Pen Live, BJ Davis shares his inspiring 158 lb weight loss journey using Mounjaro, revealing how GLP-1 medications, exe...

Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

06 Feb 2025

Contributed by Lukas

Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity. https://www.onthepen.com/post/lilly-s-earnings-call...

Novo Nordisk Q4 '24 Earnings Call: Obesity Medicine Implications

05 Feb 2025

Contributed by Lukas

From high dose semaglutide to cagrisema launch dates, Dave Knapp discusses how the latest Novo Nordisk earnings call impacts patients. Decoding GLP-1:...